Furthermore, cell titer 96 aqueous one solution (MTS) assay in ER+ve MCF-7 and ER-ve MDA-MB-231 breast cancer cell lines indicated that the ER-dependent, anti-proliferative efficacy of ENX was retained after encapsulation in DMs. The gene discussed is ESR1; the disease is breast carcinoma.